Shopping Cart 0
Cart Subtotal
USD 0

Alliqua BioMedical Inc (ALQA) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc, is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company's products comprise ultrasound healing therapy, human biologics, antimicrobial protection and hydration. Its contract manufacturing business unit provides custom hydrogels to the OEM market. Alliqua BioMedical develops and manufactures electron-beam cross-linked sheet gels for manufacturer of medical devices, cosmeceuticals, and other commercial product applications. The company's customer service professionals assist with order placement, product training, and reimbursement. It operates through its GMP manufacturing facility in Langhorne. Alliqua BioMedical is headquartered in Langhorne, Pennsylvania, the US.

Alliqua BioMedical Inc (ALQA)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Alliqua BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Alliqua BioMedical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Alliqua BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Alliqua BioMedical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Alliqua BioMedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Alliqua BioMedical Inc, Medical Equipment, Deal Details 11

Partnerships 11

BSN medical to Enter into Distribution Agreement with Alliqua BioMedical 11

Alliqua Enters Into Distribution Agreement With Sorbion 12

Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 13

Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 14

Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 15

Equity Offering 16

Alliqua BioMedical Raises USD3.8 Million in Public Offering of Shares 16

Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 18

Alliqua BioMedical Completes Public Offering of Shares for USD34.5 Million 19

Alliqua Completes Private Placement Of Shares For USD 15 Million 21

Alliqua Completes Private Placement Of Shares For USD 5.3 Million Upon Exercise Of Warrants 22

Alliqua Completes Private Placement Of Shares For USD 6 Million 23

Alliqua Completes Private Placement Of Units For USD 1 Million 25

Alliqua Completes Final Tranche Of Private Placement Of Shares For USD 2 Million 26

Alliqua BioMedical Raises USD0.54 Million in Private Placement of Shares 27

Alliqua Completes Private Placement Of Shares For USD 0.8 Million 28

Alliqua Completes Private Placement Of Units For USD 0.3 Million 29

Alliqua Completes Private Placement Of Units For USD 1.7 Million 30

Asset Transactions 31

Celularity Acquires Assets from Alliqua BioMedical for USD29 Million 31

Argentum Medical Acquires TheraBond and TheraBond 3D Antimicrobial Barrier Systems from Alliqua BioMedical for USD3.8 Million 32

Acquisition 33

Alliqua BioMedical Acquires Celleration for USD46.3 Million 33

Alliqua BioMedical Inc-Key Competitors 34

Alliqua BioMedical Inc-Key Employees 35

Alliqua BioMedical Inc-Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Recent Developments 37

Financial Announcements 37

Nov 09, 2017: Alliqua BioMedical Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial Outlook 37

Aug 10, 2017: Alliqua BioMedical Reports Second Quarter of Fiscal Year 2017 Financial Results 40

May 09, 2017: Alliqua BioMedical Reports First Quarter of Fiscal Year 2017 Financial Results 42

Apr 06, 2017: Alliqua BioMedical Announces Preliminary First Quarter Fiscal 2017 Revenue and Updates Fiscal Year 2017 Outlook 43

Mar 07, 2017: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2016 Financial Results 44

Other Significant Developments 47

Nov 09, 2017: Alliqua BioMedical Engages Cowen to Assist in Evaluating Potential Strategic Alternatives 47

Sep 05, 2017: Alliqua BioMedical Announces the Sale of TheraBond 3D Antimicrobial Barrier Systems Product Line; Alliqua Updates Fiscal Year Outlook 48

Appendix 49

Methodology 49

About GlobalData 49

Contact Us 49

Disclaimer 49


List Of Figure

List of Figures

Alliqua BioMedical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Alliqua BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Alliqua BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Alliqua BioMedical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Alliqua BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Alliqua BioMedical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Alliqua BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Alliqua BioMedical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Alliqua BioMedical Inc, Medical Equipment, Key Facts, 2017 2

Alliqua BioMedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Alliqua BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Alliqua BioMedical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Alliqua BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Alliqua BioMedical Inc, Deals By Market, 2012 to YTD 2018 9

Alliqua BioMedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

BSN medical to Enter into Distribution Agreement with Alliqua BioMedical 11

Alliqua Enters Into Distribution Agreement With Sorbion 12

Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 13

Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 14

Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 15

Alliqua BioMedical Raises USD3.8 Million in Public Offering of Shares 16

Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 18

Alliqua BioMedical Completes Public Offering of Shares for USD34.5 Million 19

Alliqua Completes Private Placement Of Shares For USD 15 Million 21

Alliqua Completes Private Placement Of Shares For USD 5.3 Million Upon Exercise Of Warrants 22

Alliqua Completes Private Placement Of Shares For USD 6 Million 23

Alliqua Completes Private Placement Of Units For USD 1 Million 25

Alliqua Completes Final Tranche Of Private Placement Of Shares For USD 2 Million 26

Alliqua BioMedical Raises USD0.54 Million in Private Placement of Shares 27

Alliqua Completes Private Placement Of Shares For USD 0.8 Million 28

Alliqua Completes Private Placement Of Units For USD 0.3 Million 29

Alliqua Completes Private Placement Of Units For USD 1.7 Million 30

Celularity Acquires Assets from Alliqua BioMedical for USD29 Million 31

Argentum Medical Acquires TheraBond and TheraBond 3D Antimicrobial Barrier Systems from Alliqua BioMedical for USD3.8 Million 32

Alliqua BioMedical Acquires Celleration for USD46.3 Million 33

Alliqua BioMedical Inc, Key Competitors 34

Alliqua BioMedical Inc, Key Employees 35

Alliqua BioMedical Inc, Subsidiaries 36

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Alliqua BioMedical Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc, is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company's products comprise ultrasound healing therapy, human biologics, antimicrobial protection and hydration. Its contract manufacturing business unit provides custom hydrogels to the OEM market. Alliqua BioMedical develops and manufactures electron-beam cross-linked sheet gels for manufacturer of medical devices, cosmeceuticals, and other commercial product applications. The company's customer service professionals assist with order placement, product training, and reimbursement. It operates through its GMP manufacturing facility in Langhorne. Alliqua BioMedical is headquartered in Langhorne, Pennsylvania, the US.

Alliqua BioMedical Inc (ALQA)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Alliqua BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Alliqua BioMedical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Alliqua BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Alliqua BioMedical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Alliqua BioMedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Alliqua BioMedical Inc, Medical Equipment, Deal Details 11

Partnerships 11

BSN medical to Enter into Distribution Agreement with Alliqua BioMedical 11

Alliqua Enters Into Distribution Agreement With Sorbion 12

Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 13

Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 14

Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 15

Equity Offering 16

Alliqua BioMedical Raises USD3.8 Million in Public Offering of Shares 16

Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 18

Alliqua BioMedical Completes Public Offering of Shares for USD34.5 Million 19

Alliqua Completes Private Placement Of Shares For USD 15 Million 21

Alliqua Completes Private Placement Of Shares For USD 5.3 Million Upon Exercise Of Warrants 22

Alliqua Completes Private Placement Of Shares For USD 6 Million 23

Alliqua Completes Private Placement Of Units For USD 1 Million 25

Alliqua Completes Final Tranche Of Private Placement Of Shares For USD 2 Million 26

Alliqua BioMedical Raises USD0.54 Million in Private Placement of Shares 27

Alliqua Completes Private Placement Of Shares For USD 0.8 Million 28

Alliqua Completes Private Placement Of Units For USD 0.3 Million 29

Alliqua Completes Private Placement Of Units For USD 1.7 Million 30

Asset Transactions 31

Celularity Acquires Assets from Alliqua BioMedical for USD29 Million 31

Argentum Medical Acquires TheraBond and TheraBond 3D Antimicrobial Barrier Systems from Alliqua BioMedical for USD3.8 Million 32

Acquisition 33

Alliqua BioMedical Acquires Celleration for USD46.3 Million 33

Alliqua BioMedical Inc-Key Competitors 34

Alliqua BioMedical Inc-Key Employees 35

Alliqua BioMedical Inc-Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Recent Developments 37

Financial Announcements 37

Nov 09, 2017: Alliqua BioMedical Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial Outlook 37

Aug 10, 2017: Alliqua BioMedical Reports Second Quarter of Fiscal Year 2017 Financial Results 40

May 09, 2017: Alliqua BioMedical Reports First Quarter of Fiscal Year 2017 Financial Results 42

Apr 06, 2017: Alliqua BioMedical Announces Preliminary First Quarter Fiscal 2017 Revenue and Updates Fiscal Year 2017 Outlook 43

Mar 07, 2017: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2016 Financial Results 44

Other Significant Developments 47

Nov 09, 2017: Alliqua BioMedical Engages Cowen to Assist in Evaluating Potential Strategic Alternatives 47

Sep 05, 2017: Alliqua BioMedical Announces the Sale of TheraBond 3D Antimicrobial Barrier Systems Product Line; Alliqua Updates Fiscal Year Outlook 48

Appendix 49

Methodology 49

About GlobalData 49

Contact Us 49

Disclaimer 49


List Of Figure

List of Figures

Alliqua BioMedical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Alliqua BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Alliqua BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Alliqua BioMedical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Alliqua BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Alliqua BioMedical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Alliqua BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Alliqua BioMedical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Alliqua BioMedical Inc, Medical Equipment, Key Facts, 2017 2

Alliqua BioMedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Alliqua BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Alliqua BioMedical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Alliqua BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Alliqua BioMedical Inc, Deals By Market, 2012 to YTD 2018 9

Alliqua BioMedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

BSN medical to Enter into Distribution Agreement with Alliqua BioMedical 11

Alliqua Enters Into Distribution Agreement With Sorbion 12

Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 13

Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 14

Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 15

Alliqua BioMedical Raises USD3.8 Million in Public Offering of Shares 16

Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 18

Alliqua BioMedical Completes Public Offering of Shares for USD34.5 Million 19

Alliqua Completes Private Placement Of Shares For USD 15 Million 21

Alliqua Completes Private Placement Of Shares For USD 5.3 Million Upon Exercise Of Warrants 22

Alliqua Completes Private Placement Of Shares For USD 6 Million 23

Alliqua Completes Private Placement Of Units For USD 1 Million 25

Alliqua Completes Final Tranche Of Private Placement Of Shares For USD 2 Million 26

Alliqua BioMedical Raises USD0.54 Million in Private Placement of Shares 27

Alliqua Completes Private Placement Of Shares For USD 0.8 Million 28

Alliqua Completes Private Placement Of Units For USD 0.3 Million 29

Alliqua Completes Private Placement Of Units For USD 1.7 Million 30

Celularity Acquires Assets from Alliqua BioMedical for USD29 Million 31

Argentum Medical Acquires TheraBond and TheraBond 3D Antimicrobial Barrier Systems from Alliqua BioMedical for USD3.8 Million 32

Alliqua BioMedical Acquires Celleration for USD46.3 Million 33

Alliqua BioMedical Inc, Key Competitors 34

Alliqua BioMedical Inc, Key Employees 35

Alliqua BioMedical Inc, Subsidiaries 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Alliqua BioMedical Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.